About us
Chief Executive Officer,
Kamran Hasanov
Dear Valued Partners and Customers,
It is with great pride that we introduce Scandens Pharmaceutical Industries Ltd., Azerbaijan’s first pharmaceutical plant with a full production cycle. Since our founding in 2016, we have committed to building a world-class facility that upholds the highest standards of quality and innovation.
Our journey began with a vision to strengthen Azerbaijan’s pharmaceutical sector by producing medicines that meet global standards. Construction of the plant started in 2017, designed by a top pharmaceutical consulting firm with experience in over 400 international projects.
Scandens operates in three stages:
- Stage One: Production of solid medicines — tablets, capsules, granules — supported by a cutting-edge Quality Control lab.
- Stage Two: Manufacturing ointments and suppositories.
- Stage Three: Sterilized products like ampoules for injections and infusions.
Currently, our plant produces 600 million tablets and 150 million capsules annually across key therapeutic areas including cardiology, diabetes, and inflammation. With over 100 generic formulations planned, we are ready to meet broad healthcare needs.
Scandens is more than a manufacturer—we are a growth partner, offering cost-effective production, tech transfer, and contract manufacturing, while opening the door for multinational companies to enter Azerbaijan and nearby markets.
Thank you for your continued trust. Together, we are building a healthier future.
Warm regards,
Kamran Hasanov, CEO
Scandens Pharmaceutical Industries Ltd.
About us
At Scandens Pharmaceutical Industries Ltd, we are driven by a shared vision to enhance global health and well-being by providing high-quality pharmaceutical products. As a newly established pharmaceutical manufacturer, we leverage cutting-edge technology, strong quality standards, and deep industry expertise to create products that make a difference in people's lives.
We believe that continuous learning is key to advancing healthcare. By fostering an environment of education and knowledge-sharing, we empower healthcare professionals, patients, and our team to stay informed about the latest advancements in the pharmaceutical industry.
CEO Message
Establishing the Future of Azerbaijan’s Pharmaceutical Industry Together
Dear partners, clients, and esteemed colleagues,
As the CEO of Scandens Pharmaceutical Industries Ltd. – a high-technology pharmaceutical industry site in Azerbaijan that carries out the full cycle of solid dosage form production through research and development (R&D) – it is a great honor and pride for me to address you.
For every professional who has dedicated their life to the pharmaceutical field, the Scandens project is more than just a company – it is a dream, a goal, and a mission. I express this on behalf of all our pharmacists, and it is a great privilege and responsibility for me to lead such a large-scale and strategically important project for our country.
Since the very first day of our operations, we at Scandens have been firmly committed to developing local production, reducing import dependency, and transforming Azerbaijan into a regional pharmaceutical hub. I extend my sincere thanks to all our partners, government institutions, and our professional team who have believed in and supported us on this path.
Alongside expanding our production capacities, we are also investing in the latest technologies, prioritizing full compliance with GMP standards, and taking consistent steps to ensure our products meet international quality requirements.
The development of local specialists is always a core focus for us. To this end, we are implementing professional development programs and placing great importance on enhancing practical knowledge and skills through the support of highly experienced foreign professionals.
All these initiatives serve one goal: to ensure that every medicine produced under the Scandens brand fully meets the criteria of high quality, safety, and effectiveness.
At Scandens, our goal goes beyond establishing long-term and sustainable partnerships, strengthening the local industry, and contributing to the health of our citizens. Creating educational and professional development opportunities based on international pharmaceutical training methodologies is also one of our main priorities. Because our mission is to establish a modern pharmaceutical industry that complies with high standards and to pass it on to future generations.
We look ahead to the coming period with great confidence and determination. We are convinced that, together, we will achieve even greater success in further strengthening our country’s pharmaceutical sector.
I express my deep gratitude to each of you for your trust in Scandens Pharmaceutical Industries Ltd. and invite you to walk alongside us on this important journey.
Sincerely,
Kamran Hasanov
Chief Executive Officer (CEO)
Scandens Pharmaceutical Industries Ltd.
Our commitments
At Scandens Pharmaceutical Industries Ltd, we are committed to more than just providing high-quality medicines. We are dedicated to making a meaningful impact in three key areas: sustainability in medicine provision, environmental responsibility, and continuous education. These commitments shape everything we do and guide us in our mission.
- Sustainability in Medicine Provision to Market: As a newly established pharmaceutical manufacturer, we leverage cutting-edge technology, strong quality standards, and deep industry expertise to create products that make a difference in people's lives. We believe that continuous learning is key to advancing healthcare. By fostering an environment of education and knowledge-sharing, we empower healthcare professionals, patients, and our team to stay informed about the latest advancements in the pharmaceutical industry.
- Environmental Responsibility: Scandens treats pharmaceutical industrial waste on-site to prevent environmental harm and minimize liquid discharge by recycling treated water for irrigation, aiming for a zero liquid discharge (ZLD) facility. The company utilizes rooftop space for solar energy, currently operating 710 panels generating 450kW with 150kW battery storage
- Educational Commitment: We believe that education is a cornerstone of improving global health. By sharing knowledge and promoting continuous learning, we aim to support healthcare professionals, patients, and students in making informed, effective decisions about their health and well-being.
Awards and certificates
Our values
We prioritize the well-being, growth, and satisfaction of our employees, customers, and partners, fostering a culture of care and respect
In the pharmaceutical industry, we uphold an uncompromising commitment to quality at every stage — from research to delivery.
We place our customers at the center of everything we do, ensuring their needs guide our innovations, services, and solutions.
We are committed to providing high-quality pharmaceutical products at affordable prices, making healthcare accessible to all.
We are dedicated to being people-oriented, prioritizing the well-being of both our customers and employees in everything we do.
We operate with strong integrity, ensuring transparency, trust, and ethical practices in all aspects of our work.
We are committed to sustainability, ensuring environmentally responsible practices and long-term value for future generations
We focus on innovation and development through dedicated R&D, continually advancing our products and processes to meet the evolving needs of healthcare.
Locations
Hokmali, Absheron District, Baku, AZ0115